Table 1.

Changes in bone marrow hematopoietic cells in response to candida infection in wild-type and G-CSF–deficient mice

Genotype Days after candida infection*Total cellularityCell type (%)
Blast Nucleated erythrocyte Promyelocyte and myelocyte Metamyelocyte and polymorph LymphocyteMonocyte Eosinophil
Wild-type  0 (9)  3.8 ± 0.3 1 ± 0.6  27 ± 1  13 ± 1  23 ± 2 25 ± 2  9 ± 1  2 ± 1  
G-CSF−/− 0 (8)  3.3 ± 0.2  2 ± 1  31 ± 2 13 ± 2  10 ± 2  34 ± 3  8 ± 1 2 ± 1  
Wild-type  3 (9)  3.5 ± 0.2  3 ± 1 17 ± 1  10 ± 1  19 ± 1  23 ± 2 13 ± 1  6 ± 1  
G-CSF−/− 3 (7) 1.7 ± 0.1,1-153 11 ± 3  20 ± 2  18 ± 1 12 ± 2  30 ± 2  13 ± 2  6 ± 1 
Wild-type  7 (10)  4.5 ± 0.3 3 ± 1 11 ± 2  20 ± 1 35 ± 3 13 ± 2 15 ± 1 3 ± 1  
G-CSF−/− 7 (7) 3.7 ± 0.1  4 ± 1  19 ± 3  27 ± 3 15 ± 1 14 ± 2  21 ± 4  0 ± 1 
Genotype Days after candida infection*Total cellularityCell type (%)
Blast Nucleated erythrocyte Promyelocyte and myelocyte Metamyelocyte and polymorph LymphocyteMonocyte Eosinophil
Wild-type  0 (9)  3.8 ± 0.3 1 ± 0.6  27 ± 1  13 ± 1  23 ± 2 25 ± 2  9 ± 1  2 ± 1  
G-CSF−/− 0 (8)  3.3 ± 0.2  2 ± 1  31 ± 2 13 ± 2  10 ± 2  34 ± 3  8 ± 1 2 ± 1  
Wild-type  3 (9)  3.5 ± 0.2  3 ± 1 17 ± 1  10 ± 1  19 ± 1  23 ± 2 13 ± 1  6 ± 1  
G-CSF−/− 3 (7) 1.7 ± 0.1,1-153 11 ± 3  20 ± 2  18 ± 1 12 ± 2  30 ± 2  13 ± 2  6 ± 1 
Wild-type  7 (10)  4.5 ± 0.3 3 ± 1 11 ± 2  20 ± 1 35 ± 3 13 ± 2 15 ± 1 3 ± 1  
G-CSF−/− 7 (7) 3.7 ± 0.1  4 ± 1  19 ± 3  27 ± 3 15 ± 1 14 ± 2  21 ± 4  0 ± 1 

Cell counts and 100-count manual leukocyte differentials were performed on mononuclear cells recovered from femurs of mice. Data are presented as mean ± SD.

*

Study day 0 is pretreatment; the value in the parentheses is the number of mice studied for that group.

Marrow cellularity is cells ×107/2 femurs.

P < .05 for comparison between mice of the same genotype at baseline and on the study day indicated.

F1-153

P < .05 for comparison between wild type and G-CSF−/− on the same study day.

Close Modal

or Create an Account

Close Modal
Close Modal